These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1856697)

  • 1. The 36K polypeptide synthesized in Newcastle disease virus-infected cells possesses properties predicted for the hypothesized 'V' protein.
    Samson AC; Levesley I; Russell PH
    J Gen Virol; 1991 Jul; 72 ( Pt 7)():1709-13. PubMed ID: 1856697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new structural protein for Newcastle disease virus.
    Chambers P; Samson AC
    J Gen Virol; 1980 Sep; 50(1):155-66. PubMed ID: 7441211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-structural proteins in Newcastle disease virus-infected cells.
    Chambers P; Samson AC
    J Gen Virol; 1982 Jan; 58 Pt 1():1-12. PubMed ID: 7142963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Mapuera virus: structure, proteins and nucleotide sequence of the gene encoding the nucleocapsid protein.
    Henderson GW; Laird C; Dermott E; Rima BK
    J Gen Virol; 1995 Oct; 76 ( Pt 10)():2509-18. PubMed ID: 7595354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anomalous behaviour of Newcastle disease virus haemagglutinin-neuraminidase protein in Western blotting analysis of monoclonal antibody binding sites.
    Samson AC
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1199-203. PubMed ID: 2423638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antigenic properties of NDV glycoproteins synthesized in the presence of 2-deoxy-d-glucose].
    Vasileva L; Neĭcheva I
    Vet Med Nauki; 1986; 23(5):29-36. PubMed ID: 3765372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation of fatty acid content of infected cells and virions with Newcastle disease virus (NDV) virulence.
    Blenkharn JI; Apostolov K
    J Gen Virol; 1981 Feb; 52(Pt 2):355-8. PubMed ID: 6169786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.
    Orvell C; Norrby E; Mufson MA
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Location of post-translational cleavage events within F and HN glycoproteins of Newcastle disease virus.
    Samson AC; Chambers P; Dickinson JH
    J Gen Virol; 1980 Mar; 47(1):19-27. PubMed ID: 7365463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies.
    Orvell C; Rydbeck R; Löve A
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature-sensitive mutant of Newcastle disease virus which has an altered nucleocapsid-associated protein.
    Samson AC; Chambers P; Lee CM; Simon E
    J Gen Virol; 1981 May; 54(Pt 1):197-201. PubMed ID: 7197299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular maturation of the Newcastle disease virus fusion protein is affected by strain differences in the predicted amphipathic alpha-helix adjacent to the fusion domain.
    Wang C; Peeples ME
    Virology; 1995 Apr; 208(2):827-31. PubMed ID: 7747459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles virus persistent infection: modification of the virus nucleocapsid protein.
    Boriskin YuS ; Bogomolova NN; Koptyaeva IB; Giraudon P; Wild TF
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1979-85. PubMed ID: 3746256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the Lassa virus nucleocapsid protein in insect cells infected with a recombinant baculovirus: application to diagnostic assays for Lassa virus infection.
    Barber GN; Clegg JC; Lloyd G
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():19-28. PubMed ID: 2406367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precursor protein for Newcastle disease virus.
    Samson AC; Fox CF
    J Virol; 1973 Sep; 12(3):579-87. PubMed ID: 4795832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of amino acid substitutions on glycosylation of the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus strain Beaudette C.
    Yusoff K; Nesbit M; Samson AC; Emmerson PT
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1549-52. PubMed ID: 2471815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of monoclonal antibody-resistant mutants of Newcastle disease virus.
    Samson AC; Russell PH; Hallam SE
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():357-61. PubMed ID: 3838186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of 2',3'-decycling phosphodiesterases in the Newcastle disease virus virion.
    Rosenbergová M; Pristasová S
    Acta Virol; 1990 Dec; 34(6):508-16. PubMed ID: 1983176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of labile Newcastle disease virus progeny after infection of chicken embryo cells in the presence of caffeine.
    Olson NJ; Consigli RA
    Am J Vet Res; 1979 Mar; 40(3):387-92. PubMed ID: 573077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotide sequence and vaccinia expression of the nucleoprotein of a highly virulent, neurotropic strain of Newcastle disease virus.
    Ward MD; Fuller FJ; Mehrotra Y; De Buysscher EV
    Avian Dis; 2000; 44(1):34-44. PubMed ID: 10737642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.